ABSTRACT: A bioinformatics-based analysis of endochondral bone formation model detected several genes upregulated in this process. Among these genes the dickkopf homolog 3 (Dkk3) was upregulated and further studies showed that its expression affects in vitro and in vivo osteogenesis. This study indicates a possible role of Dkk3 in regulating bone formation.
INTRODUCTION
In the adult, endochondral bone formation or ossification is a major process involved in both long bone development (1) and fracture healing. (2) Endochondral bone formation is a multistep process that involves numerous proteins related to cell proliferation, chondrogenesis, angiogenesis, and osteogenesis. (3) Bone morphogenetic protein-2 (BMP2) is a well-known osteogenic growth factor that has been shown to induce bone formation in vivo (4) (5) (6) and osteogenic differentiation in vitro. (7, 8) Few studies have been conducted to verify and understand the complexity of endochondral bone formation. In a rat fracture model, several Wnt-target and related genes were upregulated in fractured limbs in contrast to untreated contralateral limbs. (2) Gene expression profiling of BMP2-induced osteogenic differentiation of C2C12 cells showed upregulation of Wnt inhibitory factor-1 (Wif1). (9) Clancy et al. (10) showed a variety of genes that were differentially expressed in in vivo bone formation induced by recombinant human (rh)BMP-2 protein, such as frizzled-related protein (Frzb), and Wnt1 inducible signaling pathway protein 2 (Wisp2). These data indicate the involvement of other signaling pathways in the induction and/or regulation of endochondral bone formation.
Because of the numerous genes usually involved in the molecular regulation and signaling of osteogenic differentiation, the need for a highly efficient strategy for measuring gene expression is clear. To date, there has been no study of in vivo osteogenic differentiation of mesenchymal stem cells (MSCs) in which the focus is on a sequence of stages leading from mesenchyme to cartilage and, finally, to bone. In this study, our aim was to characterize endochondral osteogenic differentiation as a sequential process and to study the involvement of the Wnt pathway in bone formation. To achieve this goal, we used a previously described in vivo model of endochondral bone formation that includes genetically engineered MSCs that express BMP2. (11, 12) Oligonucleotide microarray analyses were performed at different time-points of endochondral bone formation, and the data analysis was accomplished by performing coupled twoway clustering (CTWC) (13) and a combination of supervised and unsupervised analysis.
Our results highlighted various molecular and cellular events taking place in endochondral bone formation at its various stages. Out of these events we have studied one of the upregulated genes, the dickkopf homolog 3 (Dkk3) gene, and assayed its role as a regulator of bone formation and maturation.
MATERIALS AND METHODS

Generation of MSC lines and in vivo transplantations
C3H10T1/2, a cell-line of MSCs that recombinantly express BMP2 (C9 cells) under the control of a Tet-off system (the expression of BMP2 is blocked by doxycycline [Dox] at 1 g/ml) were generated as described previously. (11) The cells (5 × 10 6 cells/implant) were implanted subcutaneously into 6-to 8-week-old female C3H/HeN mice (all procedures were approved by the Ethics Committee of the Authority for Animal Facilities, Hebrew University, Jerusalem, Israel). The mice (n ‫ס‬ 5 for each time-point and condition) were divided into two groups: (1) a baseline group (BAS), in which the animals received Dox in their drinking water (0.5 mg/ml); and (2) an experimental group (EXP), in which the animals were not exposed to Dox.
C3H10T1/2 cells that recombinantly express BMP2 (C3H-BMP2 cells) from the expression vector pMT7T3 (14) were generated by co-transfection with pSV2pac followed by selection with puromycin (5 g/ml). cDNA encoding murine Dkk3 (a kind gift from Dr Christof Niehrs) was recloned into pMT7T3. Stable expression of Dkk3 was obtained in C3H-BMP2 or naïve C3H10T1/2 cells resulting in two clones: C3H-BMP2-Dkk3 and C3H-Dkk3, respectively. For use as a control for C3H-BMP2-Dkk3 cells, the empty vector pMT7T3 was transfected into C3H-BMP2 cells, and for C3H-Dkk3, the empty vector pMT7T3 was transfected into C3H10T1/2 cells.
RNA extraction
The implants were harvested from animals in the BAS and EXP groups 1, 3, 5, 7, 10, 15, and 20 days after implantation. At each time-point, the implants were frozen in liquid nitrogen for total RNA extraction. Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Total RNA was used for oligonucleotide microarrays analysis, and the raw data were further analyzed using the CTWC and two-way ANOVA (see supplementary materials).
RT-PCR
RT-PCR was performed using 2 g of total RNA. The following primers were used: Dkk3, 5Ј-CGTCCTCTGA-GGTGAACCTGGC-3Ј and 5Ј-GTCTCGGGTGCA-TAGCATCTGC-3Ј; BMP2, 5Ј-CATCCCAGCCCT-CTGAC-3Ј and 5Ј-CTTTCCCACCTGCTTGCA-3Ј; collagen 1a1: 5Ј-GCCCTGCCTGCTTCGTG-3Ј and 5Ј-CGTAAGTTGGAATGGTTTTT-3Ј; collagen 2a1:
Real-time PCR was performed for BMP2, Dkk3, and RPL-19 genes using a Roche LightCycler (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's protocol. After the RT reaction (20 l), real-time PCR was conducted in a final 20-l volume by using the LightCyclerFastStart DNA Master SYBR Green I kit (Roche Diagnostics). The reaction mix contained 1× LightCycler-FastStart Master SYBR Green I, each primer at a concentration of 0.5 M, MgCl 2 at a concentration of 4 M, and 2 l cDNA from the RT reaction. Real-time PCR program conditions included one cycle at 95°C for 10 minutes to activate the modified FastStart Taq DNA polymerase, followed by 45 cycles at 95°C for 15 s, touchdown at steps of 0.5°C for 10 s, followed by a step of 72°C for 25 s. To quantify the copy number of each gene, known standards of PCR product or plasmid DNA for each gene at 10 , and 10 8 per 2 l were used to obtain the standard curves.
Adenoviral transfection
C2H-TZT and C3H-Dkk3 cells were grown, and at 80% confluence, the cells were infected with adenoviral vectors expressing the BMP2 gene (adeno-BMP2) at multiplicity of infection (MOI) of 50.
Differentiation assays
For osteogenic differentiation, ascorbic acid (50 g/ml) and 10 mM ␤-glycerophosphate were added to the media at confluence. Alkaline phosphatase (ALP) was visualized by cellular staining with Sigma Fast BCIP/NBT (Sigma Chemical, St Louis, MO, USA). For the ALP activity assay, the cells were lysed with alkaline buffer solution (Sigma Chemical) containing 0.5% Triton X100 and 10 mM MgCl 2 . The cell lysates were incubated with assay buffer containing 0.75 M 2-amino-2-methyl-1-propranolol (pH 10.3) for 10 min-utes at 37°C with p-nitrophenylphosphate as a substrate. Protein content was measured using the BCA protein assay kit (Pierce Biotechnology, Rockford, IL, USA).
For the pellet culture chondrogenic assay, 2.5 × 10 5 cells were induced by chondrogenic medium containing 1% FCS, 6.25 g/ml ITS, 50 nM ascorbic acid, and 0.1 M dexamethasone in 15-ml conical tubes. At 4 weeks of induction, part of the pellets were taken for Alcian blue staining, and the rest was taken for dimethylmethylene blue (DMMB) assay to measure the levels of glycosaminoglycans (GAGs). Total protein levels (measured using the BCA protein assay kit) were used to normalize the GAGs quantities. At 1, 3, 5, 7, 10, 15 , and 20 days after implantation, C9 implants were harvested for H&E histology. At 2 weeks after implantation of C3H-BMP2 or C3H-BMP2-Dkk3 cells, bone formation in the quadriceps muscle region of implanted animals was evaluated by performing a histological study in which Masson's trichrome staining was used. A quantitative morphometric analysis of the bone mass was undertaken detecting bone formation with the aid of CT scanning (microCT 40; Scanco). For each animal, the area of new bone formation in the injection site was scanned, marked, and measured using CT 3D reconstruction and an analysis of total bone volume (mm 3 ).
Evaluation of bone formation in vivo
Imaging of osteogenic induction in vivo
In vivo imaging of the osteogenic induction exerted by the engineered MSCs was performed in transgenic mice expressing luciferase under the control of osteocalcin promoter (OC-Luc) (15) and a light-detection cooled chargecoupled device (CCCD; Roper Scientific, Princeton Instrument, Trenton, NJ, USA). The CCCD camera tracked osteocalcin expression by visualizing luciferase activity, which was detected after the intraperitoneal injection of beetle luciferin (Promega, Madison, WI, USA) in PBS at a dose of 126 mg/kg body weight. Luciferin was injected 10 minutes before light emission was monitored. The animals were examined with a bioluminescent CCCD camera at 7, 14, and 21 days after implantation. The number of integrated light units measured at the implantation site during a 120-s period was divided by the number of integrated light units measured at the tail of the same mouse. A quantitative analysis of luciferase expression was performed with the aid of MetaImaging series 4.6 software (Universal Imaging, Downingtown, PA, USA) using a constant measurement field for all time-points. The results are presented in relative luciferase units.
RESULTS
Genetically engineered MSCs form endochondral bone tissue in vivo
The C9 cells that had been implanted in mice in the EXP group were found to induce endochondral bone formation with distinct features at each stage of the process, as shown by H&E-stained histological sections (Fig. 1A) . A histological analysis of the forming tissue revealed a dynamic differentiation process that could be roughly divided into three major phases: mesenchyme encompassed days 1-5, representing proliferation and recruitment of cells; chondrogenesis encompassed days 5-10, during which cartilage appeared; and angiogenesis began as the cartilage matured in its transition to bone, which occurred between days 10 and 15. The third "mature" phase consisted of days 10-20, during which mature cartilage and bone could be seen (Fig.  1A ).
Expression profiles of key genes
After we observed the dynamics of endochondral bone formation in vivo, total RNA was extracted from implants and hybridized to two different Affymetrix oligonulceotide microarrays: U74 (v1 and v2) and Mu1a. We filtered the data in the manner described in the supplementary materials by using T ‫ס‬ 0.6 for the Mu1a data set. This filtering left us with ∼400 genes. The U74v2 dataset was filtered using T ‫ס‬ 0.8, which left us with ∼3000 genes.
In the next step, we looked at the expression profile of key genes representing each stage (Figs. 1B-1G). Cysteinerich protein 61 (Cyr61) promotes fibroblast chemotaxis and proliferation, as well as the differentiation of various connective tissue cell types (Fig. 1B) . Procollagen type II ␣ 1 and type X (Col2a1 [ Fig. 1C] and Col10 [ Fig. 1D ], respectively) are genes that characterize the chondrogenic phase. Runt-related transcription factor 2 (Runx2 [ Fig. 1E] ) is a marker of osteoblasts and hypertrophic chondrocytes. (16, 17) Osteocalcin (Fig. 1F ) is a late marker of bone formation, and Cathepsin K (Ctsk) is a marker of osteoclasts and its presence signifies the beginning of the remodeling phase (Fig. 1G ). The expression profiles of these genes were selected from the data independent of the clustering analysis.
After filtering, we used either CTWC (unsupervised analysis) or two-way ANOVA followed by clustering (combined supervised-unsupervised analysis) to provide insight into the molecular dynamics of endochondral bone formation.
Molecular characterization of endochondral bone formation by clustering analysis
Unsupervised analysis: This analysis was performed, using CTWC, on genes that passed the filtering step, yielding several clusters in both microarrays. Clusters of genes were chosen according to their stability (13) and their ability to separate samples into BAS and EXP groups. In the U74 chips, we focused on a cluster of 64 genes, G1 ( Fig. 2A) . Genes in this cluster displayed low expression in BAS and early EXP samples, but their expression values rose in middle and late EXP samples. Cluster G1 was found to separate the samples into BAS and EXP groups and also to order the EXP samples chronologically (early-, mid-, and late-EXP; Fig. 2A ). Furthermore, one could see two kinds of genes: (1) genes whose expression increased early (days [3] [4] [5] and decreased at the late stages of the experiment (days 15-20, genes 1-33 in Fig. 2A ) and (2) genes whose expression increased at the midstage of the experiment (days 7-10) and remained elevated in the late stages of the experiment (genes 34-60 in Fig. 2A) . The genes identified in cluster G1 encode for proteins that include extracellular matrix (ECM), growth factors, proteoglycans, and other types of proteins. From this cluster, we looked for genes that may likely to be involved in endochondral bone formation based on their clustering with the known genes. In cluster G1 ( Fig. 2A) , we identified three genes related to the Wnt signaling pathway: Frzb-1, Dkk3, and Mfrp (Table 1 ; full list of genes in cluster G1 is provided in Table G1 in supplementary tables) .
Combined supervised/unsupervised analysis: We searched for genes that (1) had distinctive temporal variations of expression and (2) the observed time dependence was different in the two groups, BAS and EXP. Initially, we used two-way ANOVA to find genes that satisfied these two conditions (see supplementary materials). In the second (unsupervised) step of clustering, genes that passed the FDR filter, we assigned them to clusters with similar temporal variations. Using this method, we uncovered some very interesting clusters of genes. Here we focus on three of these clusters: G2, G3, and G4.
In cluster G2 (Mu1a microarray; Fig. 2B ), functional categorization showed that this cluster contained collagens and proteases, proliferation, angiogenesis-related proteins such as TGF-␤1, TGF-␤3, Cyr61, and Pdgf-rb. In addition, this cluster included many adhesion-related genes such as cadherins and integrin ligands, which mediate cell-to-cell adhesions and cell-to-matrix proteins, respectively. Genes that are involved in the commitment of MSCs to chondrogenesis and osteogenesis including BMP2/4 receptor, BMP1, Smad6 (Madh6), and the follistatins, which are inhibitors of BMP signaling were also included. Interestingly, G2 also contains several Wnt-related genes including the following: frizzled 2 (Fzd2), frizzled 8 (Fzd8), and Wnt1-inducible signaling pathway protein 2 (Wisp2). Runx2, a transcription factor involved in bone differentiation, was also present in this cluster ( Table 1 , full list of genes in cluster G2 is provided in Table G2 in supplementary tables). The G2 cluster represented mainly angiogenesis and the early and late events of chondrogenesis.
In cluster G3, the increase in gene expression started earlier. Already obvious on day 10, there was a slight decrease in gene expression on day 20 (Fig. 2C ). This cluster (Mu1a microarray) contained six genes ( Table 1) . Four of them (Lipc, Mmp9, Ctsk, and Fap) were degradation enzymes, one (Bglap-rs1) encoded a protein that constituted the bone matrix, and the last gene (Ckb) encoded a protein involved in energy transfer ( Fig. 2C; Table 1 ).
To determine whether the presence of Wnt-related genes was consistent in other clusters, we looked at another cluster of genes, G4. Cluster G4 was found in the analysis of the U74v2 chip and contained ∼80 genes (Fig. 2D) . The genes in this cluster showed very distinct functional groups that consisted of a large number of collagen genes and ECM proteins, genes related to the Wnt pathway, various bonerelated genes (such as Bambi, a BMP, and activin inhibitor), and Runx1, which is a transcription factor possibly involved in bone development and proteolytic degradation enzymes (Table 1 ). In addition, there were a few proteoglycans, which are recognized as part of the ECM but also play a role in signal transduction of various pathways including the Wnt pathway. (18) The G4 cluster contained Wnt-related genes including Frzb-1, Dkk3, and Wnt inhibitory factor 1 (Wif1). This is consistent with the presence of Wnt-related genes, which we observed in the previous clusters (G1 and G2). It also suggests a correlation with the Wnt signaling pathway and Wnt-regulatory factors in BMP2-induced endochondral bone formation (full list of genes in cluster G4 is provided in Table G4 in supplementary tables).
Confirmation of Dkk3 expression
Among the many genes that were found in the CTWC analysis, a consistent presence of Wnt-related genes was observed in all the clusters. Based on the bioinformatics, functional categorization, and a literature search performed regarding Wnt-related genes, we found Dkk3 to be an intriguing gene because there is no reports of any obvious function it may have in chondrogenesis or osteogenesis. To study the involvement of Dkk3 in in vivo bone formation, we initially confirmed the expression of Dkk3 during the process of in vivo bone formation by performing a real-time quantitative RT-PCR. In the BAS samples, expression levels of Dkk3 remained almost constant according to both the quantitative RT-PCR and oligonucleotide microarray analyses (Figs. 3A and B, respectively) . In the EXP samples, peak levels of expression were detected on day 7 in the quantitative RT-PCR analysis (Fig. 3A) and on day 10 in the microarrays analysis (Fig. 3B) .
Effects of Dkk3 on in vitro chondrogenesis and osteogenesis
To study the effects of Dkk3 on chondrogenic and osteogenic differentiation of mesenchymal progenitor cells, two cell clones, C3H-BMP2 and C3H-BMP2-Dkk3, were generated and cultured for several time periods. These two clones expressed similar levels of BMP2 mRNA, as shown by quantitative RT-PCR (Fig. 3C) . The C3H-BMP2-Dkk3 clone expressed ∼1000-fold higher levels of Dkk3 mRNA than the C3H-BMP2 clone, which expressed low levels of endogenous Dkk3 (Fig. 3C ). These levels of Dkk3 and BMP2 gene expression remained stable over time during the osteogenic and chondrogenic differentiation assays (data not shown).
The proliferation rate of the clones was measured. At day 3 of growth, there was no significant difference in the number of C3H-BMP2 and C3H-BMP2-Dkk3 cells. From day 3 to day 5 of growth, the C3H-BMP2 clone exhibited a significantly higher proliferation rate compared with the C3H-BMP2-Dkk3 clone (Fig. 4A) . After day 5, the number of C3H-BMP2 cells remained higher; however, the prolifera- 4A ). There was no evidence of cell death during the growth of the cells before reaching confluence. When osteogenesis was evaluated, C3H-BMP2 cells exhibited higher levels of ALP at 9 and 12 days compared with C3H-BMP2-Dkk3. This was shown both by the activity assay and by ALP histochemical staining, which showed in situ levels of ALP (Figs. 4B and 4C, respectively) . In addition, an RT-PCR analysis showed a decrease in collagen Ia1 mRNA expression in the C3H-BMP2-Dkk3 cells in contrast to the C3H-BMP2 cells, which showed an increase in this gene expression (Fig. 4D) . Osteocalcin, which is a late marker of osteogenesis, was expressed at higher levels on days 7, 10, and 14 in the C3H-BMP2 clone (Fig. 4D) . To verify the in vitro effects of Dkk3 in osteogenesis, we used another two clones that do not express BMP2 but either express only Dkk3 (C3H-Dkk3) or contain empty vector (C3H-TZT). Osteogenic induction was initiated by either adeno-BMP2 infection (Fig. 4E) or by adding rhBMP2 (Fig.  4F) . The adeno-BMP2 infection resulted in BMP2 mRNA expression similar to that expressed in C3H-BMP2 and C3H-BMP2-Dkk3 cells (data not shown). C3H-TZT cells exhibited significantly higher levels of ALP expression than C3H-Dkk3 at all time-points except in day 12 in the adeno-BMP2 infection group. When chondrogenesis was examined, Alcian blue staining and DMMB assay of GAGs showed no significant difference in chondrogenic differentiation of either C3H-BMP2 compared with C3H-BMP2-Dkk3 and C3H-TZT compared with C3H-Dkk3 (Figs. 4G  and 4H ). In addition, RT-PCR showed similar levels of collage IIa1 mRNA in both C3H-BMP2 and C3H-BMP2-Dkk3 during chondrogenic differentiation (Fig. 4D) .
Effects of Dkk3 on in vivo bone formation
To study the effects of Dkk3 expression on in vivo bone formation, we took the advantage of noninvasive real-time bioluminescence imaging of OC-Luc mice that express luciferase at sites of active osteogenesis. This noninvasive imaging enable detecting and quantifying in vivo bone formation in a longitudinal manner. On day 7 after implantation, luciferase activity was significantly higher in hind-limbs with implants of C3H-BMP2 cells than in hind-limbs with implants of C3H-BMP2-Dkk3 cells (Figs. 5A and 5B). This indicates higher active osteogenesis at the site of C3H-BMP2 implantation, which is an effect of secreted BMP-2, and lower levels of osteogenesis at the site of C3H-BMP2-Dkk3 implantation. On days 14 and 21 after implantation, the two clones showed the same level of luciferase activity (Figs. 5A and 5B). CT scans showed the formation of ectopic bone at both thigh muscles injected with C3H-BMP2 cells and those injected with C3H-BMP2-Dkk3 cells (Figs. 5C and 5D, respectively) . Cross-sections of ectopic bone displayed constructions of bone trabeculae with no prominent difference between the two clones; however, in the C3H-BMP2 implants, the trabeculae were larger and thicker than in the C3H-BMP2-Dkk3 implants (Figs. 5E and 5F, respectively). A quantitative analysis of the CT scans revealed significantly higher levels of bone formation in the C3H-BMP2 clones compared with the C3H-BMP2-Dkk3 (Fig. 5G) . Histological analysis of the implants revealed characteristics of endochondral bone formation in both C3H-BMP2 and C3H-BMP2-Dkk3 implants (Figs. 5H and 5I, respectively). The main phases of endochondral bone formation were evident, meaning a mesenchymal cell phase and a chondrogenesis phase, which proceeds to an osteogenesis phase that ends in mature bone tissue (Fig.  5H) .
DISCUSSION
Endochondral bone formation is an outcome of the sequential expression of many genes with different roles and various time intervals of action. In this study, we showed a selective bioinformatics "dissection" of the process by focusing on major clusters of genes that represent each major stage. Each histological phase was also shown at the molecular level by the expression phase of a representative Cells were plated, and at confluence, ascorbic acid (50 g/ml) and 10 mM ␤-glycerophosphate were added to the media. ALP production was assessed by performing (B) an ALP activity assay or (C) ALP staining. (D) RT-PCR analysis of differentiation markers. For the RT-PCR analysis, RNA was purified from the cells during osteogenic differentiation and used for RT-PCR for collagen Ia1, osteocalcin, or during chondrogenic differentiation and used for RT-PCR for collagen IIa1. (E and F) Osteogenic differentiation of C3H-TZT and C3H-Dkk3 cells. C3H-TZT and C3H-Dkk3 were either infected with adeno-BMP2 (MOI ‫ס‬ 50, E) or the medium was supplemented with 50 ng/ ml rhBMP2 (F). Medium was also supplemented with ascorbic acid (50 g/ml) and 10 mM ␤-glycerophosphate. ALP production was assessed by performing an ALP activity assay at the time-points indicated in the graph. (G) Effects of Dkk3 on chondrogenic differentiation. Each of the indicated cell lines was induced to undergo chodrogenic differentiation. C3H-TZT and C3H-Dkk3 cells were first infected with adeno-BMP2 (MOI ‫ס‬ 50). AT 4 weeks of induction, pellets were either taken for histological analysis of (G) Alcian blue staining or (H) for DMMB assay.
gene as shown in Fig. 1 . The expression of well-known genes in endochondral bone formation such as Runx2 and its target gene osteocalcin, Col2a1, and Col10 (Figs. 2B-2G ) in the profiles we observed confirm the reliability of the model and the microarrays analysis.
After these histological and molecular analyses of in vivo differentiation of the C9 clone, unsupervised clustering pinpointed the main genes that could partition samples into two separate groups of EXP and BAS ( Fig. 2A) . These gene clusters were "enriched" with chondrogenesis-and osteogenesis-related genes, confirming again the reliability of the microarrays analysis after clustering analysis ( Table 1) .
Each of the three clusters-G2, G3, and G4-included many genes that may be involved in each stage of bone formation. Briefly, cluster G2 ( Fig. 2B; Table 1 ) is the first significant cluster to show both early and late events of chondrogenesis based on the expression of several previously identified genes. Cluster G3 may represent the stage of remodeling, as indicated by the upregulation of Ctsk and Mmp9 and their patterns of expression, that is, upregulation at late time-points ( Fig. 2C ; Table 1 ). Cluster G4 may represent the step of matrix deposition in both chondrogenesis and osteogenesis, based on the observed expression of several collagens and proteoglycans (Fig. 2D) .
Based on the clustering analysis that was applied for the microarrays data, we hypothesized that candidate genes that have expression profile that is similar to genes with known function in the process can be chosen from the representative clusters such as G2, G3, and G4. One of the candidate genes that were chosen for further research was Dkk3. The choice of this candidate gene was based on the little knowledge that we found in the literature describing the function of this gene in bone formation and on the fact that the confirmation of this gene expression using quantitative RT-PCR showed a similar pattern of expression that correlates with the microarrays results. In addition, we examined the expression of other Wnt members using quantitative RT-PCR. However, we did not find the same correlation to the arrays results as in the Dkk3 results (data not shown). Based on these results, the Dkk3 was cloned into the C3H10T1/2 cell line and studied, aiming to put some light on the function of Dkk3 in osteogenesis and chondrogenesis.
Dkk3 is a member of the dickkopf family of morphogens that also includes Dkk1, Dkk2, and Dkk4, which have been identified as exerting antagonist activity against the Wnt signaling pathway. (19) Wnts constitute a group of secreted signaling glycoproteins that play an important role in many different fundamental processes, including embryonic axis specification, cell fate determination, differentiation, and organogenesis. (20, 21) Monasghan et al. (22) have shown that all Dkks (Dkk1, Dkk2, and Dkk3) show distinct and elevated expression patterns in tissues that mediate mesenchyme-epithelial transitions, indicating that they may participate in the induction of heart, tooth, hair and whisker follicle, limb, and bone. Recent studies have shown that Dkk3 is not a Wnt inhibitor. (23) Expression of Dkk3 peaked on days 10 (microarrays) and 7 (RT-PCR), and its endogenous expression in MSCs was very low in wildtype cells (data not shown) and in C3H-BMP2 cells (Fig. 3C) , indicating that in vitro BMP2 expression does not upregulate Dkk3 expression. However, Dkk3 is upregulated in the complete process of in vivo bone formation rather than directly upregulated by elevated levels of BMP2 in vitro.
An interesting finding was that clones expressing Dkk3 exhibited a lower rate of proliferation in vitro (Fig. 4A) and reduced osteogenic differentiation (Figs. 4B-4F ) compared with cells that do not express Dkk3, leading us to infer an inhibitory effect of MSC differentiation through a cell cycle-mediated mechanism. This result is supported by other studies that showed inhibition of Saos-2 osteosarcoma cell line proliferation (24) and inhibition of these cells' motility and invasion (25) after transfection with Dkk3, suggesting a regulatory role of Dkk3 during the proliferation and migration of mesenchyme in endochondral bone formation. Furthermore, it was recently reported that activation of the Wnt signaling pathway using LiCl accelerates osteogenesis in human MSCs, whereas Dkk1, a Wnt inhibitor, has a reversal effect on osteogenesis. (26) Verification of the involvement of Dkk3 in in vivo bone formation was obtained using C3H-BMP2 and C3H-BMP2-Dkk3 clones. It may be assumed that a lower level of bone is attributed to dual effect of Dkk3 by the decreased proliferation of MSCs and inhibition of these cells' commitment to the osteogenic lineage, which leads to a decrease in in vivo bone formation.
The in vivo effect of Dkk3 on BMP2-induced bone formation was first shown by using OC-Luc transgenic mice, in which significantly higher levels of luciferase activity were shown on day 7 after an injection of C3H-BMP2 cells than after an injection of C3H-BMP2-Dkk3 cells (Figs. 5A and 5B). This indicates that the maximal effect of Dkk3 on BMP2-induced osteogenesis occurs on day 7 of the process, a fact that fits our finding that there is a peak in Dkk3 expression on day 7 (RT-PCR) and day 10 (microarrays) during endochondral bone formation (Figs. 3A and 3B ).
Based on our finding that Dkk3 is upregulated in C9 implants, it is reasonable to think that Dkk3 will be upregulated in C3H-BMP2 implants in the same manner as in C9 implants, therefore reducing the differences between the two clones in relation to osteogenesis. The reason we only observed a significant effect of Dkk3 in C3H-BMP2-Dkk3 cells was because Dkk3 is constitutively expressed in this clone, resulting in a continuous effect on the process. Nevertheless, the Dkk3 effect remains maximal on days 7-10 after injection, as we found in the bioluminescence imaging studies (Figs. 5A and 5B).
The CT images revealed larger amounts of newly formed bone in the C3H-BMP2 implants than in the C3H-BMP2-Dkk3 implants (Figs. 5C, 5D , and 5G). The CT cross-sections (Figs. 5E and 5F) and the histological analysis (Figs. 5H and 5I) showed that there is no difference in the "quality" of the newly formed bone (i.e., the calcification level and the bone components at the cellular level).
These findings clearly show a potential role for Dkk3 in the regulation of in vivo bone formation. The role of Dkk3 in the Wnt signaling pathway is still unclear even though it was excluded to be a Wnt inhibitor. (23) Various Wnt genes have been found expressed in unique spatial and temporal patterns during skeletogenesis and osteogenesis. (27) (28) (29) (30) Frzb-1, a natural antagonist of certain Wnts, was found to be expressed during cartilage development and to regulate chondrocyte maturation and long bone development during limb skeletogenesis. Our observations of Dkk3 expression at the transition from cartilage to bone (days 7-10), a negative effect on osteogenesis with no effect on chondrogenesis, suggest a role for Dkk3 that is similar to that of Frzb-1 in skeletogenesis, that is, the regulation of chondrocyte maturation during endochondral bone formation. The expression of both Wnt-activating factors (Wnt5b) and Wnt inhibitors (Frzb-1 and Wif1) in the same cluster (cluster G3; Table 1 ) is corroborated by the physiological regulation during the transition from cartilage to bone. This step is regulated by both "transition inducers" (Wnt5b, Fzd2, and Fzd8) and "transition inhibitors" (Frzb-1 and Wif1), resulting in regulated, well-controlled bone formation. Dkk3 may have a role as a transition inhibitor, therefore, acting as a regulator of bone maturation. Further studies at the mechanism level would clarify the exact involvement of Dkk3 and its effect on Wnt pathway during endochondral bone formation.
